Lincoln Park Capital Fund LLC 13D/13G Filings for Salarius Pharmaceuticals, Inc. (SLRX)

Lincoln Park Capital Fund LLC 13D and 13G filings for Salarius Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-04-27
10:52 am
Purchase
2022-04-22 13G Salarius Pharmaceuticals, Inc.
SLRX
Lincoln Park Capital Fund LLC 14,849
5.980%
14,849increase
(New Position)
Filing